logo-loader
JPMorgan Chase & Co

JPMorgan beats market consensus with strong 1Q revenue from equity trading

Earnings of US$2.37 per share on revenue of US$32.3bn vs. an estimated US$2.31 a share

A J.P Morgan office
The beat was driven by gains across every key business line, with higher rates benefiting the bank

JPMorgan Chase & Co. (NYSE:JPM) reported earnings on Friday that beat on both the top and bottom line, with a big jump in profitability on the back of strong trading results and an improving interest-rate environment.

The bank reported first quarter March 2018 earnings of US$2.37 per share on revenue of US$32.3bn. The Earnings Whisper number was US$2.31 per share. There was plenty of good news in J.P. Morgan's quarterly earnings report with revenue growing 16.8% on a year-over-year basis.

READ: JP Morgan shares ease premarket after corporate investment banking numbers disappoint

J.P Morgan shares were up over 1% at US$114.60 in pre-market trading.

Bank earnings season kicked off Friday with J.P Morgan, Citigroup, and Wells Fargo reporting first-quarter results.

Markets revenue grew overall by 7%, excluding items, helped by a 25% growth in stock trading.

"2018 is off to a good start with our businesses performing well across the board, driving strong top-line growth and building on the momentum from last year," J.P Morgan CEO Jamie Dimon said in a statement.

"The global economy continues to do well, and we remain optimistic about the positive impact of tax reform in the U.S. as business sentiment remains upbeat, and consumers benefit from job and wage growth," added Dimon.

Quick facts: JPMorgan Chase & Co

Price: $107.72

Market: NYSE
Market Cap: $344.43 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

15 hours, 43 minutes ago

2 min read